Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah M Groves

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Network Physiology|September 21, 2023
Quantifying cancer cell plasticity with gene regulatory networks and single-cell dynamicsSarah M Groves, Vito Quaranta
Cancers|March 11, 2023
Involvement of Epithelial-Mesenchymal Transition Genes in Small Cell Lung Cancer Phenotypic PlasticitySarah M Groves, Nicholas Panchy, Darren R Tyson, et al.
Molecular Systems Biology|September 27, 2024
Proteome-wide copy-number estimation from transcriptomicsAndrew J Sweatt, Cameron D Griffiths, Sarah M Groves, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Cahn-Hilliard dynamical models for condensed biomolecular systemsSarah M Groves, Min-Jhe Lu, Astrid Catalina Alvarez-Yela, et al.
Plos Computational Biology|November 1, 2019
Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizersDavid J Wooten, Sarah M Groves, Darren R Tyson, et al.
Genes & Development|May 21, 2021
ASCL1 represses a SOX9<sup>+</sup> neural crest stem-like state in small cell lung cancerRachelle R Olsen, Abbie S Ireland, David W Kastner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2021
Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLCPortia L Thomas, Sarah M Groves, Yun-Kai Zhang, et al.
Cell Systems|August 18, 2022
Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancerSarah M Groves, Geena V Ildefonso, Caitlin O McAtee, et al.
Cancer Cell|January 22, 2021
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M Gay, C Allison Stewart, Elizabeth M Park, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Network Physiology|September 21, 2023
Quantifying cancer cell plasticity with gene regulatory networks and single-cell dynamicsSarah M Groves, Vito Quaranta
Cancers|March 11, 2023
Involvement of Epithelial-Mesenchymal Transition Genes in Small Cell Lung Cancer Phenotypic PlasticitySarah M Groves, Nicholas Panchy, Darren R Tyson, et al.
Molecular Systems Biology|September 27, 2024
Proteome-wide copy-number estimation from transcriptomicsAndrew J Sweatt, Cameron D Griffiths, Sarah M Groves, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Cahn-Hilliard dynamical models for condensed biomolecular systemsSarah M Groves, Min-Jhe Lu, Astrid Catalina Alvarez-Yela, et al.
Plos Computational Biology|November 1, 2019
Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizersDavid J Wooten, Sarah M Groves, Darren R Tyson, et al.
Genes & Development|May 21, 2021
ASCL1 represses a SOX9<sup>+</sup> neural crest stem-like state in small cell lung cancerRachelle R Olsen, Abbie S Ireland, David W Kastner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2021
Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLCPortia L Thomas, Sarah M Groves, Yun-Kai Zhang, et al.
Cell Systems|August 18, 2022
Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancerSarah M Groves, Geena V Ildefonso, Caitlin O McAtee, et al.
Cancer Cell|January 22, 2021
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M Gay, C Allison Stewart, Elizabeth M Park, et al.
Pageof 1